Update on Phase II Trials for Amgens Once Weekly GLP-1 Injection MariTide Key Takeaways The Phase II trial of MariTide revealed high discontinuation rates, particularly among participants without Type 2 diabetes, largely due to gastrointestinal adverse events, including nausea and vomiting
: Gnoni A, Longo S, Gnoni GV, Giudetti AM
One of the earliest recognized actions of incretin hormones is the enhancement of glucose-dependent insulin secretion, which accounts for greater insulin release and lower glycemic responses following oral compared to intravenous glucose administration (Mller et al., 2019)
Selenium Contributes to antioxidant defense
Who Is Eligible For GLP-1 Therapy
Plasma and tissue GSH levels decline with age, while markers of oxidative damage increase, creating a "redox imbalance" implicated in the pathogenesis of age-related diseases [2][3][10][11]